Supplementary materials: Off-label antipsychotic use patterns among Texas Medicaid adults 2013–2016

This is a peer-reviewed supplementary table for the article 'Off-label antipsychotic use patterns among Texas Medicaid adults 2013–2016' published in the Journal of Comparative Effectiveness Research.

• Supplementary Table 1: Diagnosis and ICD-9-CM, ICD-10-CM Codes

Summary: Aim: To describe trends in off-label antipsychotic use among Texas Medicaid adults and examine whether demographic and clinical characteristics were associated with off-label use. Methods: Three diagnostic groups (i.e. no diagnosis, on label and off-label) were created based on mental health disorder diagnoses and related antipsychotic prescriptions. Results: During 2013–2016, the prevalence of off-label antipsychotic use decreased from 22.5% to 17.4% and the proportions of no mental health diagnosis remained stable (7.3–9.4%). Patients aged ≥25 years and second-generation antipsychotic users had significantly lower odds of receiving antipsychotics off-label or with no diagnosis. Conclusion: Compared with previous Medicaid database studies, the proportions of off-label antipsychotic use and antipsychotic use with no concurrent psychiatric diagnosis were notably lower.